TIMP-1 as a tumor marker in breast cancer – An update
Author:
Publisher
Informa UK Limited
Subject
Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1080/02841860802022976
Reference51 articles.
1. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
2. Do we need better prognostic factors in node-negative breast cancer?
3. First—select the target: better choice of adjuvant treatments for breast cancer patients
4. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
5. New functions for the matrix metalloproteinases in cancer progression
Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification and immune landscape of sarcopenia-related molecular clusters in inflammatory bowel disease by machine learning and integrated bioinformatics;Scientific Reports;2024-07-30
2. Bioinformatics mining and experimental validation of prognostic biomarkers in colorectal cancer;2024-04-29
3. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03
4. Comparative profiling by data-independent acquisition mass spectrometry reveals featured plasma proteins in breast cancer: a pilot study;Annals of Surgical Treatment and Research;2024
5. TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma;Aging;2023-09-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3